IT1392813B1 - Forme cristalline di dexlansoprazolo - Google Patents

Forme cristalline di dexlansoprazolo

Info

Publication number
IT1392813B1
IT1392813B1 ITMI2009A000157A ITMI20090157A IT1392813B1 IT 1392813 B1 IT1392813 B1 IT 1392813B1 IT MI2009A000157 A ITMI2009A000157 A IT MI2009A000157A IT MI20090157 A ITMI20090157 A IT MI20090157A IT 1392813 B1 IT1392813 B1 IT 1392813B1
Authority
IT
Italy
Prior art keywords
dexlansoprazole
crystalline forms
crystalline
forms
Prior art date
Application number
ITMI2009A000157A
Other languages
English (en)
Inventor
Gabriele Razzetti
Chiara Vladiskovic
Original Assignee
Dipharma Francis Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dipharma Francis Srl filed Critical Dipharma Francis Srl
Priority to ITMI2009A000157A priority Critical patent/IT1392813B1/it
Priority to EP12165293A priority patent/EP2487173A1/en
Priority to EP10151500A priority patent/EP2216333A3/en
Priority to EP14200470.4A priority patent/EP2907812B1/en
Priority to US12/693,539 priority patent/US8362260B2/en
Publication of ITMI20090157A1 publication Critical patent/ITMI20090157A1/it
Application granted granted Critical
Publication of IT1392813B1 publication Critical patent/IT1392813B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
ITMI2009A000157A 2009-02-06 2009-02-06 Forme cristalline di dexlansoprazolo IT1392813B1 (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ITMI2009A000157A IT1392813B1 (it) 2009-02-06 2009-02-06 Forme cristalline di dexlansoprazolo
EP12165293A EP2487173A1 (en) 2009-02-06 2010-01-25 Amorphous form of dexlansoprazole
EP10151500A EP2216333A3 (en) 2009-02-06 2010-01-25 Crystalline forms of Dexlansoprazole
EP14200470.4A EP2907812B1 (en) 2009-02-06 2010-01-25 Process for the preparation of an amorphous form of dexlansoprazole
US12/693,539 US8362260B2 (en) 2009-02-06 2010-01-26 Crystalline forms of dexlansoprazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2009A000157A IT1392813B1 (it) 2009-02-06 2009-02-06 Forme cristalline di dexlansoprazolo

Publications (2)

Publication Number Publication Date
ITMI20090157A1 ITMI20090157A1 (it) 2010-08-07
IT1392813B1 true IT1392813B1 (it) 2012-03-23

Family

ID=40673609

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2009A000157A IT1392813B1 (it) 2009-02-06 2009-02-06 Forme cristalline di dexlansoprazolo

Country Status (3)

Country Link
US (1) US8362260B2 (it)
EP (3) EP2487173A1 (it)
IT (1) IT1392813B1 (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011004387A2 (en) * 2009-06-18 2011-01-13 Matrix Laboratories Ltd Process for the preparation of dexlansoprazole polymorphic forms
IT1395118B1 (it) * 2009-07-29 2012-09-05 Dipharma Francis Srl Procedimento per la preparazione di dexlansoprazolo cristallino
US8318943B1 (en) * 2010-04-16 2012-11-27 Takeda Pharmaceuticals U.S.A., Inc. Sorbitol/dexlansoprazole co-crystals and method for making same
EP2663306A4 (en) * 2011-01-12 2014-01-01 Hetero Research Foundation POLYMORPHS OF DEXLANSOPRAZOLE SALTS
WO2012104805A1 (en) * 2011-02-01 2012-08-09 Ranbaxy Laboratories Limited Process for the preparation of dexlansoprazole
ITMI20112219A1 (it) * 2011-12-05 2013-06-06 Dipharma Francis Srl Forme cristalline di dexlansoprazolo
WO2015067657A1 (en) * 2013-11-05 2015-05-14 Basf Se Process for the oxidation of organic carbonyl compounds
CN104650035A (zh) * 2013-11-25 2015-05-27 天津市汉康医药生物技术有限公司 右兰索拉唑倍半水合物化合物
IT201700050223A1 (it) * 2017-05-09 2018-11-09 Dipharma Francis Srl Procedimento per la preparazione di dexlansoprazolo cristallino

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4035455A1 (de) 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
TWI275587B (en) * 1999-06-17 2007-03-11 Takeda Chemical Industries Ltd A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
KR100775802B1 (ko) * 2000-04-28 2007-11-12 다케다 야쿠힌 고교 가부시키가이샤 광학 활성 술폭시드 유도체의 제조 방법
CN100562318C (zh) * 2000-05-15 2009-11-25 武田药品工业株式会社 晶体的制备方法
AU2002218506A1 (en) * 2000-12-01 2002-06-11 Takeda Chemical Industries Ltd. Process for the crystallization of (r)- or (s)-lansoprazole
KR20040093187A (ko) * 2002-03-27 2004-11-04 테바 파마슈티컬 인더스트리즈 리미티드 란소프라졸 다형 및 그것의 제조 방법
ES2534713T3 (es) * 2002-10-16 2015-04-27 Takeda Pharmaceutical Company Limited Preparaciones sólidas estables
ATE508124T1 (de) * 2003-03-24 2011-05-15 Eisai R&D Man Co Ltd Verfahren zur herstellung von amorphem rabeprazole-natrium-salz
US20100286400A1 (en) * 2007-12-31 2010-11-11 Takeda Pharmaceutical Company Limited Crystalline solvated forms of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole
EP2265605A4 (en) * 2008-03-18 2011-08-03 Reddys Lab Ltd Dr METHOD OF MANUFACTURING DEXLANSOPRAZOLE AND POLYMORPHIDE THEREOF

Also Published As

Publication number Publication date
EP2907812A1 (en) 2015-08-19
EP2907812B1 (en) 2017-12-13
US20100204479A1 (en) 2010-08-12
EP2216333A2 (en) 2010-08-11
EP2216333A3 (en) 2010-10-27
EP2487173A1 (en) 2012-08-15
US8362260B2 (en) 2013-01-29
ITMI20090157A1 (it) 2010-08-07

Similar Documents

Publication Publication Date Title
HK1254977A1 (zh) 索非布韋(sofosbuvir)的結晶形式
LTPA2018008I1 (lt) Kristalai
SMT201600075B (it) Composto di diamminocarbossammide eterociclica
SMT201600254B (it) Procedimento per la preparazione di idromagnesite
BRPI0915714A2 (pt) forma cristalina de posaconazol
DK2262793T3 (da) Krystallinske former af nilotinib-hci
DOP2012000114A (es) Inhibidor bromodominio de benzodiazepina
IT1392813B1 (it) Forme cristalline di dexlansoprazolo
ECSP12011999A (es) Derivados benzamida sustituidos
BRPI1008744A2 (pt) hidrotratamento de caboidratos
SMT201600031B (it) Composti eterociclici di fenossimetile
BR112012005382A2 (pt) inibidores de jak
SMT201500268B (it) Derivato di 5-idrossipirimidin-4-carbossammide
BRPI1008007A2 (pt) derivados de piridazinona substituídos por heteroarila
DK2453858T3 (da) Fremgangsmåde
DK2506840T3 (da) Anvendelser af hæmmere af hypoksi-fremkaldende faktorer
SMT201700085B (it) Forma cristallina di pemirolast
IT1395118B1 (it) Procedimento per la preparazione di dexlansoprazolo cristallino
IT1395963B1 (it) Forme cristalline di 6-(1h-imidazol-1-il)-2-fenil chinazolina e dei suoi sali
IT1397895B1 (it) Procedimento per la compensazione di quadratura
CU23884B1 (es) Derivados de dibenzotiazepina
IT1395736B1 (it) Forme cristalline di rufinamide
IT1398273B1 (it) Procedimento per la preparazione di 14-bromo daunomicina
TH105747B (th) รูปแบบผลึกของไนโตรเคทิคอล
IT1393671B1 (it) Composizione di inchiostro